Evidium

Evidium

Evidium builds what it terms world models for healthcare — computational maps of clinical states, transitions, and causal drivers that aim to make medical knowledge actionable. The firm serves self-insured employers, health plans, health systems, and research organizations, projecting patient trajectories to forecast disease progression and cost. Its platform triangulates claims data, clinical notes, and real-world evidence, grounding each insight in traceable clinical evidence. Evidium's strategy centers on a software platform that models longitudinal patient journeys rather than providing isolated diagnostic or treatment recommendations. The firm designates its technology as Computational Medical Intelligence, distinct from generative AI applications. The platform allows payers and providers to align financial planning with clinical reality by forecasting severity, cost trajectories, and intervention outcomes. Supporting investors include specialist funds PGV, Interwoven Ventures, and Mindset Ventures. The firm maintains a distributed footprint with personnel in Louisville, Chicago, San Diego, Chapel Hill, Menlo Park, San Francisco, and Portsmouth. Evidium is built by a multidisciplinary team of engineers, scientists, and clinicians, though it has not publicly disclosed a headcount or named its leadership team. Its investor roster includes the venture studio of the American Medical Association, Health2047, and WGG Partners, a specialist deep-tech fund with early-stage positions in x.AI and Perplexity. Evidium's structural differentiator is its grounding in a computational, evidence-traceable model of disease dynamics rather than a pattern-matching language model. By projecting patients across a computable map of conditions and the transitions between them, the firm supplies a substrate on which AI agents can reason about clinical consequences before recommending actions — a design choice that separates it from LLM-centric healthcare startups.